GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD)
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 9, 2018 Category: Drugs & Pharmacology Authors: CristinaRebordosa , EstelPlana , JaumeAguado , StevenThomas , EstherGarc ía-Gil , SusanaPerez‐Gutthann , JordiCastellsague Source Type: research

Real world management of pregestational diabetes not achieving glycemic control for many patients in the UK
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 9, 2018 Category: Drugs & Pharmacology Authors: LuciaCea ‐Soriano , Luis A.García‐Rodríguez , Kimberly G.Brodovicz , ElviraGonzalez‐Masso , Dorothee B.Bartels , SoniaHernández‐Díaz Source Type: research

Antidepressant and antipsychotic medication errors reported to United States poison control centers
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 9, 2018 Category: Drugs & Pharmacology Authors: AlishaKamboj , Henry A.Spiller , Marcel J.Casavant , ThitphalakChounthirath , Nichole L.Hodges , Gary A.Smith Source Type: research

Trends in the long ‐term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 4, 2018 Category: Drugs & Pharmacology Authors: TerhiKurko , Leena K.Saastamoinen , AnnamariTuulio ‐Henriksson , TeroTaiminen , JariTiihonen , MarjaAiraksinen , JarmoHietala Source Type: research

Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non ‐compliance: Survey among French‐speaking health care professionals and patients in Belgium
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 4, 2018 Category: Drugs & Pharmacology Authors: M élanieLelubre , JamilaHamdani , ChristelleSenterre , KarimAmighi , MarionPeres , Marie‐PauleSchneider , OlivierBugnon , CarineDe Vriese Source Type: research

Issue Information
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 5, Page 556-556, May 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 3, 2018 Category: Drugs & Pharmacology Source Type: research

Issue Information
Pharmacoepidemiology and Drug Safety,Volume 27, Issue 5, Page 1-4, May 2018. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - May 3, 2018 Category: Drugs & Pharmacology Source Type: research

Reuse of data sources to evaluate drug safety signals: When is it appropriate?
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 27, 2018 Category: Drugs & Pharmacology Authors: Shirley V.Wang , MartinKulldorff , Robert J.Glynn , Joshua J.Gagne , AntonPotteg ård , Kenneth J.Rothman , SebastianSchneeweiss , Alexander M.Walker Source Type: research

Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance “lock‐in” program
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 27, 2018 Category: Drugs & Pharmacology Authors: Rebecca B.Naumann , Stephen W.Marshall , Nisha C.Gottfredson , Jennifer L.Lund , Christopher L.Ringwalt , Asheley C.Skinner Source Type: research

Impact of different assumptions on estimates of childhood diseases obtained from health care data: A retrospective cohort study
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 25, 2018 Category: Drugs & Pharmacology Authors: Osemeke U.Osokogu , AlexandraPacurariu , MeesMosseveld , PeterRijnbeek , DanielWeibel , KatiaVerhamme , Miriam C.J.M.Sturkenboom Source Type: research

Using prescription claims to detect aberrant behaviors with opioids: comparison and validation of 5 algorithms
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 24, 2018 Category: Drugs & Pharmacology Authors: KathrynRough , Krista F.Huybrechts , SoniaHernandez ‐Diaz , Rishi J.Desai , ElisabettaPatorno , Brian T.Bateman Source Type: research

Assessing the accuracy of using diagnostic codes from administrative data to infer antidepressant treatment indications: a validation study
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 24, 2018 Category: Drugs & Pharmacology Authors: JennaWong , MichalAbrahamowicz , David L.Buckeridge , RobynTamblyn Source Type: research

Assumptions made when preparing drug exposure data for analysis have an impact on results: An unreported step in pharmacoepidemiology studies
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 18, 2018 Category: Drugs & Pharmacology Authors: Stephen R.Pye , Th érèseSheppard , Rebecca M.Joseph , MarkLunt , NadyneGirard , Jennifer S.Haas , David W.Bates , David L.Buckeridge , Tjeerd P.van Staa , RobynTamblyn , William G.Dixon Source Type: research

Positive predictive value of a register ‐based algorithm using the Danish National Registries to identify suicidal events
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 17, 2018 Category: Drugs & Pharmacology Authors: ChristianeGasse , Andreas Aalkj ærDanielsen , Marianne GiørtzPedersen , Carsten BøckerPedersen , OleMors , JakobChristensen Source Type: research

A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post ‐Authorization Studies
Pharmacoepidemiology and Drug Safety, EarlyView. (Source: Pharmacoepidemiology and Drug Safety)
Source: Pharmacoepidemiology and Drug Safety - April 17, 2018 Category: Drugs & Pharmacology Authors: PareenVora , EstherArtime , MontseSoriano ‐Gabarró , NawabQizilbash , VineetSingh , AlexAsiimwe Source Type: research